Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Biohit: Preconditions for a turnaround

Biohit

Biohit is focused on diagnostics of the gastrointestinal tract and health-promoting products. The company has shown the first signs of a turnaround after a long loss-making period. We believe that the development of new products and successful commercialization are key to the company's long-term success. Analyst Antti Siltanen tells more about the company.

Read more about Biohit: https://www.inderes.se/research/biohit-sustainability-of-turnaround-being-tested

00:00 Intro
00:26 Biohit’s business
01:56 International markets
03:18 Competitive advantages
04:20 Product development
05:53 Strategy
07:18 Profitability and financial targets
08:51 Outlook
10:32 Valuation

Stay up to date
Analyst Interviews

Recent videos

Arjo, Audiocast, Q4'25
30.01.2026, 13.00 Arjo
AKTIER MED FRIIS - UGE 5 2026
30.01.2026, 12.00
Midsona, Audiocast, Q4'25
30.01.2026, 11.00 Midsona
Elisa, Webcast, Q4'25
30.01.2026, 11.00 Elisa
Beijer Ref, Audiocast, Q4'25
30.01.2026, 10.00 Beijer Ref
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.